Sign In
12 May 2011 16:13
For immediate release 12 May 2011
MedicX Fund Limited
("MedicX Fund", "the Fund" or "the Company")
Block listing six monthly return
Name of applicant: | MedicX Fund Limited | |||
Name of scheme: | General Corporate Purposes | |||
Period of return: | From: | 12/11/10 | To: | 11/05/11 |
Balance of unallotted securities under scheme(s) from previous return: | 2,500,000 | |||
Plus: The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for): | Nil | |||
Less: Number of securities issued/allotted under scheme(s) during period (see LR3.5.7G): | 1,100,000 | |||
Equals: Balance under scheme(s) not yet issued/allotted at end of period: | 1,400,000 | |||
End
For further information please contact:
MedicX Fund +44 (0) 1481 723 450
David Staples, Chairman
MedicX Group +44 (0) 1483 869 500
Keith Maddin, Chairman
Mike Adams, Chief Executive Officer
Mark Osmond, Chief Financial Officer
Collins Stewart Europe Limited +44 (0) 20 7523 8000
Andrew Zychowski/Helen Goldsmith
Buchanan Communications +44 (0) 20 7466 5000
Charles Ryland/Suzanne Brocks
Information on MedicX Fund Limited
MedicX Fund Limited ("MXF", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom, listed on the London Stock Exchange, with a portfolio comprising 59 properties.
The Investment Adviser to the Company is MedicX Adviser Ltd, which is authorised and regulated by the Financial Services Authority and is a subsidiary of the MedicX Group. The MedicX Group is a specialist investor, developer and manager of healthcare properties with 31 people operating across the UK.
The Company's website address is www.medicxfund.com. Neither the contents of the Company's website nor the contents of any website accessible from hyperlinks on the Company's website (or any other website) is incorporated into, or forms part of, this announcement.
Follow the stocks
